PMID- 12427122 OWN - NLM STAT- MEDLINE DCOM- 20030523 LR - 20061115 IS - 0085-2538 (Print) IS - 0085-2538 (Linking) VI - 62 IP - 6 DP - 2002 Dec TI - Endocytosis of light chains induces cytokines through activation of NF-kappaB in human proximal tubule cells. PG - 1977-88 AB - BACKGROUND: In proteinuric states increased cytokine production through endocytosis of filtered proteins by proximal tubule cells (PTCs) has been proposed as a major mechanism mediating tubulointerstitial injury and progressive kidney disease. We studied the effects of six different light chains (LCs) on the production of cytokines in cultured human PTCs. METHODS: LCs were isolated and purified from the urine of patients with myeloma and human PTCs were exposed to either LC or human serum albumin (HSA) for up to 24 hours. LC endocytosis was monitored by immunocytochemistry. Cytokines were determined by enzyme-linked immunosorbent assay (ELISA) in the supernatants and activation of nuclear factor-kappa B (NF-kappaB) was detected by electrophoretic mobility shift assays (EMSA) and immunocytochemistry. RESULTS: Endocytosis of LCs induced the release of interleukins (IL) IL-6, IL-8 and monocyte chemoattractant protein-1 (MCP-1); however, there was considerable variability among the six different LCs. In contrast, HSA had no effect on cytokine production even at very high concentrations. Removal of LC-containing media resulted in cessation of IL-6 release. LC-induced cytokine release was associated with nuclear translocation of NF-kappaB subunits p50 and p65, as demonstrated by both EMSA and immunocytochemistry. Inhibitors of NF-kappaB, aspirin and pyrrolidineditiocarbamate (PDTC) markedly suppressed LC-induced cytokine production. CONCLUSION: LC endocytosis leads to production of inflammatory cytokines through activation of NF-kappaB. This may be an important mechanism of chronic tubulointerstitial inflammation process commonly seen in multiple myeloma. These findings also point out a potential role by filterable low-molecular-weight proteins, like LCs, in PTC injury during all proteinuric diseases. FAU - Sengul, Sule AU - Sengul S AD - Department of Medicine, Section of Nephrology, Tulane Medical Center, Tulane Cancer Center, and Veterans Administration Medical Center, New Orleans, Louisiana, USA. FAU - Zwizinski, Craig AU - Zwizinski C FAU - Simon, Eric E AU - Simon EE FAU - Kapasi, Aditi AU - Kapasi A FAU - Singhal, Pravin C AU - Singhal PC FAU - Batuman, Vecihi AU - Batuman V LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Kidney Int JT - Kidney international JID - 0323470 RN - 0 (Chemokine CCL2) RN - 0 (Immunoglobulin Light Chains) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) RN - 0 (Serum Albumin) SB - IM MH - Cells, Cultured MH - Chemokine CCL2/biosynthesis/metabolism MH - Electrophoretic Mobility Shift Assay MH - *Endocytosis MH - Fluorescent Antibody Technique, Indirect MH - Humans MH - Immunoglobulin Light Chains/metabolism/*pharmacology MH - Interleukin-6/biosynthesis/metabolism MH - Interleukin-8/biosynthesis/metabolism MH - Kidney Tubules, Proximal/*cytology/*metabolism MH - Multiple Myeloma/metabolism MH - NF-kappa B/antagonists & inhibitors/*metabolism MH - Serum Albumin/pharmacology EDAT- 2002/11/13 04:00 MHDA- 2003/05/24 05:00 CRDT- 2002/11/13 04:00 PHST- 2002/11/13 04:00 [pubmed] PHST- 2003/05/24 05:00 [medline] PHST- 2002/11/13 04:00 [entrez] AID - S0085-2538(15)48765-4 [pii] AID - 10.1046/j.1523-1755.2002.00660.x [doi] PST - ppublish SO - Kidney Int. 2002 Dec;62(6):1977-88. doi: 10.1046/j.1523-1755.2002.00660.x.